Technology
Health
Biotechnology

Harvard Bioscience

$2.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.42%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell HBIO and other stocks, options, ETFs, and crypto commission-free!

About

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. Read More It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Employees
547
Headquarters
Holliston, Massachusetts
Founded
1901
Market Cap
88.94M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
168.24K
High Today
$2.43
Low Today
$2.34
Open Price
$2.34
Volume
97.63K
52 Week High
$6.70
52 Week Low
$2.26

Collections

Technology
Health
Biotechnology
US
North America

News

Seeking AlphaMay 3

Harvard Bioscience, Inc. (HBIO) CEO Jeffrey Duchemin on Q1 2019 Results - Earnings Call Transcript

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Corey Manchester – Vice President and Corporate Controller Jeffrey Duchemin – President and Chief Executive Officer Kam Unninayar – Chief Financial Officer Conference Call Participants Paul Knight – Janney Montgomery Bruce Jackson – Benchmark Lisa Springer – Singular Research Operator Welcome to the Q1 2019 Harvard Bioscience Incorporated Earnings Conference Call. My name is Adrienne...

92
Seeking AlphaMay 3

Harvard Bio down 16% on Q1 miss, guidance cut

Thinly traded micro cap Harvard Bioscience (HBIO -15.7% ) is down on modestly higher volume, albeit on turnover of only 140K shares, in reaction to its Q1 results released after the close yesterday.

70
NasdaqMay 2

Harvard Bioscience (HBIO) Lags Q1 Earnings and Revenue Estimates

Harvard Bioscience (HBIO) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share.

7

Earnings

$0.02
$0.04
$0.05
$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Jul 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.